Increasing Diversity In Clinical Trials through Synthetic Data

Background

Desire to explore the use of synthetic data in biopharma to unlock new markets and bring this groundbreaking technology to address challenges such as cost and timescale of clinical trials; drug discovery and diversity of patient selection for clinical trials.

Solution

Demonstrator for Synthetic data to highlight how the technology could address diversity and at risk patient issue via Generative Adversarial Networks and simulation.

Focused on education of Clinical Operations professionals and Chief Medical and Scientific officers of target organisations.

Outcome

Trialled with Chief Medical Officers increasing uptake of the technology.